Preclinical efficacy of MEK inhibition in NRAS mutant acute myeloid leukemia Meeting Abstract


Authors: Burgess, M. R.; Hwang, E.; Firestone, A. J.; Huang, T. N.; Xu, J.; Zuber, J.; Bohin, N.; Wen, T.; Kogan, S. C.; Haigis, K. M.; Lowe, S. W.; Shannon, K.; Li, Q.
Abstract Title: Preclinical efficacy of MEK inhibition in NRAS mutant acute myeloid leukemia
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349243502046
PROVIDER: wos
DOI: 10.1182/blood.V124.21.3753.3753
Notes: Meeting Abstract: 3753 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Scott W Lowe
    249 Lowe